Moderna vaccine progress a 'positive development' according to former FDA commissioner, but 'there's a lot of work ahead'
May 19, 2020
Early data on a coronavirus vaccine candidate is encouraging, but there's still "a lot of work" to be done, the former commissioner of the FDA says.
Moderna on Monday announced some "positive" interim data on its potential COVID-19 vaccine, saying that eight patients in a phase one trial developed antibodies at levels similar to those who recovered from the coronavirus.
READ MORE